April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
IL-22 Has A Suppressive Effect In Experimental Autoimmune Uveitis (EAU)
Author Affiliations & Notes
  • Hui Shao
    Ophthal & Visual Sciences, University of Lousiville, Louisville, Kentucky
  • Yan Ke
    Ophthal & Visual Sciences, University of Lousiville, Louisville, Kentucky
  • Guomin Jiang
    Ophthal & Visual Sciences, University of Lousiville, Louisville, Kentucky
  • Henry J. Kaplan
    Ophthal & Visual Sciences, University of Lousiville, Louisville, Kentucky
  • Deming Sun
    DVRC-411, Doheny Eye Institute, Los Angeles, California
  • Footnotes
    Commercial Relationships  Hui Shao, None; Yan Ke, None; Guomin Jiang, None; Henry J. Kaplan, None; Deming Sun, None
  • Footnotes
    Support  Supported in part by NIH grants NEI EY12974 (HS), Research to Prevent Blindness (RPB) Lew R. Wasserman Merit Award (HS), and the Department's RPB Unrestricted Grant (HK).
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2952. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hui Shao, Yan Ke, Guomin Jiang, Henry J. Kaplan, Deming Sun; IL-22 Has A Suppressive Effect In Experimental Autoimmune Uveitis (EAU). Invest. Ophthalmol. Vis. Sci. 2011;52(14):2952.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previous studies have shown that while IL-17+ IRBP-specific T cells have a strong pathogenic effect in EAU, the major cytokine produced by these cells-IL-17 does not always have proinflammatory effects. IL-22, one of the cytokines chiefly produced by IL-17+ CD4 cells, has also been reported to have paradoxical effects during tissue inflammation. We wanted to determine the role of IL-22 in the pathogenesis of EAU.

Methods: : Uveitis was induced in B10RIII mice by immunization with the 161-180 peptide of interphotoreceptor retinoid-binding protein (IRBP). Then the mice received two i.p. injections of recombinant IL-22 on days 4 and 8 after immunization. Ocular inflammation was examined by funduscopy and histology. Proliferation, cytokine production and disease inducing ability of responder T cells from IL-22 treated or non-treated mice were determined and compared. Expression of IL-22 receptor (IL-22R) on immune cell subsets was examined by RT-qPCR. Effects of IL-22 on APC both in vivo and in vitro were examined by their production of cytokines, expression of costimulatory molecules and interaction with IRBP-T cells.

Results: : Administration of IL-22 significantly inhibited the development of EAU. Mice treated with IL-22 generated decreased numbers of IFN-γ autoreactive T cells but increased numbers of Foxp3+ regulatory T cells, which was due to regulatory APCs induced by IL-22. These APCs expressed high levels of PD-L1 and produced increased amounts of IL-10 and TGF-β. Moreover, IRBP specific T cells in the presence IL-22 treated APCs lost their uveitogenic intensity, but acquired immunosuppressive activity. These T cells suppressed EAU induced by pathogenic IRBP effector T cells.

Conclusions: : Treatment of animals undergoing induction of EAU with IL-22 inhibits the development of EAU-i.e. it is anti-inflammatory. This effect is mediated by regulatory APCs that bestow effector T cells with regulatory activities.

Keywords: immunomodulation/immunoregulation • uveitis-clinical/animal model • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×